IP Library Assignment 065489/0809
Patent Assignment
Reel/Frame 065489/0809

Change of Name

Recorded: 2023-11-07 Pages: 6
Assignor
OLATEC THERAPEUTICS LLC
Executed: 2023-09-15
Assignee
OLATEC THERAPEUTICS, INC.
800 FIFTH AVENUE, 25TH FLOOR, NEW YORK, NEW YORK, 10065
Covered Properties (45)
Composition for Treating Bacterial, Viral, Fungal Diseases, Inflammation and Pain
Patent: 7,423,064 →
Application: 11/234,874 →
Publication: US 2006/0069160
3-Methanesulfonylpropionitrile for Treating Inflammation and Pain
Patent: 8,476,316 →
Application: 13/324,777 →
Publication: US 2012/0157524
3-Methanesulfonylpropionitrile for Treating Inflammation and Pain
Patent: 8,829,046 →
Application: 13/759,676 →
Publication: US 2013/0172410
Process for Preparing 3-Methylsulfonylpropionitrile
Patent: 8,802,885 →
Application: 13/777,754 →
Publication: US 2013/0225865
3-Methanesulfonylpropionitrile for Treating Inflammation and Pain
Patent: 8,975,297 →
Application: 14/216,664 →
Publication: US 2014/0228433
Crystalline Form of 3-Methylsulfonylpropionitrile
Patent: 9,024,056 →
Application: 14/335,709 →
Publication: US 2014/0330037
Pharmaceutical Composition and Use of Diethyl (2-Cyanoethyl)Phosphonate
Patent: 9,149,488 →
Application: 14/463,479 →
Publication: US 2015/0057252
Method for Treating Skin Inflammatory Diseases
Patent: 9,078,869 →
Application: 14/552,366 →
Publication: US 2015/0080476
Pharmaceutical Composition Comprising Omega-(Arylsulfonyl)Alkylnitrile
Patent: 9,481,644 →
Application: 14/554,848 →
Publication: US 2015/0087701
Compounds for Treating Inflammation and Pain
Patent: 9,205,067 →
Application: 14/562,608 →
Publication: US 2015/0094373
Compounds for Treating Inflammation and Pain
Patent: 9,114,122 →
Application: 14/562,620 →
Publication: US 2015/0094366
3-Methanesulfonylpropionitrile for Treating Inflammation and Pain
Patent: 9,492,420 →
Application: 14/639,781 →
Publication: US 2015/0231106
Process for Preparing 3-Methylsulfonylpropionitrile
Patent: 9,399,620 →
Application: 14/699,934 →
Publication: US 2015/0232421
Method for Treating Contact Dermatitis
Patent: 9,278,082 →
Application: 14/796,809 →
Publication: US 2016/0008314
Compounds for Treating Inflammation and Pain
Patent: 9,474,734 →
Application: 14/832,681 →
Publication: US 2016/0184255
Method for Treating Inflammation and Pain
Patent: 9,439,880 →
Application: 14/958,165 →
Publication: US 2016/0158171
Process for Preparing 3-(Methylsulfonyl)Propionitrile
Patent: 9,815,781 →
Application: 15/045,447 →
Method for Treating Skin Inflammatory Diseases
Patent: 9,592,217 →
Application: 15/062,936 →
Publication: US 2016/0256430
3, 4-Bis-Benzylsulfonylbutyronitrile and Its Pharmaceutical Use
Patent: 9,440,916 →
Application: 15/078,179 →
Publication: US 2016/0200675
Pharmaceutical Use of 3-Benzylsulfonylpropionitrile
Patent: 9,999,610 →
Application: 15/083,513 →
Publication: US 2016/0206589
4-Methylsulfonyl-2-Butenenitrile and Its Pharmaceutical Use
Patent: 9,522,878 →
Application: 15/084,816 →
Publication: US 2016/0207881
4-Benzylsulfonyl-2-Butenenitrile
Patent: 9,987,246 →
Application: 15/245,513 →
Publication: US 2016/0361286
Pharmaceutical Composition
Application: 15/260,554 →
Publication: US 2017/0065542
Pharmaceutical Use of 3, 4-Bis-Benzylsulfonylbutyronitrile
Patent: 9,750,714 →
Application: 15/262,176 →
Publication: US 2017/0065550
Pharmaceutical Composition for Treating Inflammation and Pain
Application: 15/299,688 →
Publication: US 2017/0100364
Pharmaceutical Composition Comprising Omega-(Arylsulfonyl)Alkylnitrile
Patent: 9,889,111 →
Application: 15/339,196 →
Publication: US 2017/0105962
3-Methanesulfonylpropionitrile for Treating Inflammation and Pain
Patent: 9,770,428 →
Application: 15/349,161 →
Publication: US 2017/0119725
Methods for Treating Inflammation and Pain
Patent: 9,763,909 →
Application: 15/363,384 →
Publication: US 2017/0143660
4-Methylsulfonyl-2-Butenenitrile and Its Pharmaceutical Use
Patent: 9,770,429 →
Application: 15/380,146 →
Publication: US 2017/0231944
3-Methanesulfonylpropionitrile for Treating Inflammation and/or Pain
Application: 15/712,269 →
Publication: US 2018/0125807
Pharmaceutical Composition for Treating Inflammation and Pain
Application: 15/837,283 →
Publication: US 2018/0353459
Deuterated 3-Methanesulfonylpropionitrile
Application: 15/945,542 →
Publication: US 2018/0290971
Pharmaceutical Use of 3-Benzylsulfonylpropionitrile
Application: 16/007,858 →
Publication: US 2018/0303787
3-Methanesulfonylpropionitrile for Treating Inflammation and/or Pain
Application: 16/139,351 →
Publication: US 2019/0133988
Methods for Treating Cardiovascular Diseases
Application: 16/452,189 →
Publication: US 2019/0307718
Method for Treating Multiple Sclerosis
Application: 16/458,595 →
Publication: US 2019/0321325
3-Methanesulfonylpropionitrile for Treating Inflammation and/or Pain
Application: 16/704,921 →
Publication: US 2020/0237706
Method for Preventing or Treating Alzheimer's Disease
Application: 16/942,312 →
Publication: US 2020/0352897
Methods for Treating Melanoma
Application: 17/021,733 →
Publication: US 2020/0405681
Method for Treating Asthma
Application: 17/457,420 →
Publication: US 2022/0087969
Methods for Treating Breast Cancer
Application: 17/659,121 →
Publication: US 2022/0249425
Method for Treating Diabetes
Application: 17/934,526 →
Publication: US 2023/0028615
Method for Preventing or Treating Lung Infection and Lung Inflammation
Application: 17/995,167 →
Publication: US 2023/0330054
Methods for Treating Cardiovascular Diseases
Application: 18/165,908 →
Publication: US 2023/0277496
Pharmaceutical Composition for Treating Inflammation and Pain
Application: 18/185,935 →
Publication: US 2023/0372279
Related Assignments (11)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement May 10, 2001
From: AGCO CORPORATION
To: COOPERATIVE CENTRALE RAIFFAISEN-BOERENLEENBANK, B.A., "RABOBANK" NEDERLAND, NEW YORK BRANCH, AS ADMINISTRATIVE AGENT
Reel/Frame 011742/0375 →
Assignment of Assignor's Interest Dec 5, 2005
From: TORRENCE, CHRISTOPHER
To: OLATEC INDUSTRIES LLC
Reel/Frame 016854/0303 →
Assignment of Assignor's Interest Dec 14, 2011
From: ST. LAURENT, JOSEPH
To: OLATEC INDUSTRIES LLC
Reel/Frame 027394/0023 →
Assignment of Assignor's Interest Mar 27, 2013
From: ST. LAURENT, JOSEPH P.; JONES, GERALD S.; BRESSE, DAVID M.
To: OLATEC INDUSTRIES LLC.
Reel/Frame 030099/0471 →
Assignment of Assignor's Interest Apr 3, 2015
From: ST. LAURENT, JOSEPH; JONES, GERALD S.; BRESSE, DAVID M.
To: OLATEC INDUSTRIES LLC
Reel/Frame 035333/0642 →
Assignment of Assignor's Interest Jul 29, 2015
From: ST. LAURENT, JOSEPH P.
To: OLATEC INDUSTRIES LLC
Reel/Frame 036212/0147 →
Assignment of Assignor's Interest Aug 14, 2015
From: ST. LAURENT, JOSEPH P.; JONES, GERALD S.; BRESSE, DAVID M.
To: OLATEC INDUSTRIES LLC
Reel/Frame 036333/0346 →
Assignment of Assignor's Interest Aug 14, 2015
From: ST. LAURENT, JOSEPH P.; JONES, GERALD S.; BRESSE, DAVID M.
To: OLATEC INDUSTRIES LLC
Reel/Frame 036333/0509 →
Assignment of Assignor's Interest Feb 23, 2016
From: JONES, GERALD S.; GOODRICH, SCOTT A.
To: OLATEC THERAPEUTICS LLC
Reel/Frame 037803/0610 →
Assignment of Assignor's Interest Mar 16, 2016
From: ST. LAURENT, JOSEPH P.; JONES, GERALD S.; BRESSE, DAVID M.; GOODRICH, SCOTT A.
To: OLATEC INDUSTRIES LLC
Reel/Frame 038000/0184 →
Change of Name Mar 18, 2016
From: OLATEC INDUSTRIES LLC
To: OLATEC THERAPEUTICS LLC
Reel/Frame 038177/0824 →